International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company (MISX:GEMA) acquired 6.93% stake in Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ) on February 1, 2022.

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company (MISX:GEMA) completed the acquisition of 6.93% stake in Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ) on February 1, 2022.